These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 7674334

  • 1. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC.
    J Natl Cancer Inst; 1995 Oct 04; 87(19):1470-6. PubMed ID: 7674334
    [Abstract] [Full Text] [Related]

  • 2. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.
    Cancer; 2001 Nov 15; 92(10):2699-708. PubMed ID: 11745206
    [Abstract] [Full Text] [Related]

  • 3. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H.
    Cancer; 2005 Jan 01; 103(1):174-80. PubMed ID: 15549714
    [Abstract] [Full Text] [Related]

  • 4. Implication of unfavorable histology, MYCN amplification and diploidy for stage I and II neuroblastomas.
    de Buys Roessingh AS, Rougemont AL, Wiesenauer C, Barrette S, Bouron-Dal Soglio D, Lallier M.
    Eur J Pediatr Surg; 2008 Dec 01; 18(6):410-4. PubMed ID: 19012235
    [Abstract] [Full Text] [Related]

  • 5. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC.
    J Natl Cancer Inst; 1993 Mar 03; 85(5):377-84. PubMed ID: 8433391
    [Abstract] [Full Text] [Related]

  • 6. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A, Matsuoka K, Okita H, Iwafuchi H, Hori H, Kumagai M.
    Pediatr Dev Pathol; 2011 Mar 03; 14(2):87-92. PubMed ID: 21288077
    [Abstract] [Full Text] [Related]

  • 7. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 8. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D.
    N Engl J Med; 1985 Oct 31; 313(18):1111-6. PubMed ID: 4047115
    [Abstract] [Full Text] [Related]

  • 9. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 10. Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator.
    Nakagawara A, Ikeda K, Tsuda T, Higashi K, Okabe T.
    J Pediatr Surg; 1987 May 15; 22(5):415-8. PubMed ID: 3585663
    [Abstract] [Full Text] [Related]

  • 11. Clinical implications of oncogene activation in human neuroblastomas.
    Brodeur GM, Seeger RC, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D.
    Cancer; 1986 Jul 15; 58(2 Suppl):541-5. PubMed ID: 3719548
    [Abstract] [Full Text] [Related]

  • 12. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
    Altungoz O, Aygun N, Tumer S, Ozer E, Olgun N, Sakizli M.
    Cancer Genet Cytogenet; 2007 Jan 15; 172(2):113-9. PubMed ID: 17213019
    [Abstract] [Full Text] [Related]

  • 13. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.
    Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimizu K.
    Cancer; 1987 Aug 15; 60(4):820-6. PubMed ID: 3594401
    [Abstract] [Full Text] [Related]

  • 14. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
    George RE, Variend S, Cullinane C, Cotterill SJ, McGuckin AG, Ellershaw C, Lunec J, Pearson AD, United Kingdom Children Cancer Study Group.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):169-76. PubMed ID: 11464876
    [Abstract] [Full Text] [Related]

  • 15. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P.
    Cancer; 2002 Feb 01; 94(3):854-61. PubMed ID: 11857322
    [Abstract] [Full Text] [Related]

  • 16. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
    Teshiba R, Kawano S, Wang LL, He L, Naranjo A, London WB, Seeger RC, Gastier-Foster JM, Look AT, Hogarty MD, Cohn SL, Maris JM, Park JR, Shimada H.
    Pediatr Dev Pathol; 2014 Feb 01; 17(6):441-9. PubMed ID: 25207821
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic significance of MYCN amplification in children neuroblastic tumors].
    Niu H, Xu T, Wang F, Chen Z, Gao Q, Yi P, Xia J.
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb 01; 44(2):111-7. PubMed ID: 25916642
    [Abstract] [Full Text] [Related]

  • 18. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
    Tornóczky T, Kálmán E, Kajtár PG, Nyári T, Pearson AD, Tweddle DA, Board J, Shimada H.
    Cancer; 2004 Jan 15; 100(2):390-7. PubMed ID: 14716776
    [Abstract] [Full Text] [Related]

  • 19. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK.
    Cancer; 2001 Nov 01; 92(9):2451-61. PubMed ID: 11745303
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O, Navarro S, Noguera R, Pellín A, Ruiz A, Castel V, Llombart-Bosch A.
    Virchows Arch; 2006 Oct 01; 449(4):410-20. PubMed ID: 16941154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.